• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.87% Nasdaq Up 0.34%

    InVivo Therapeutics Holdings Corp. (NVIV)

    -Other OTC
    1.35 Down 0.07(5.21%) 3:59PM EST
    Add to Portfolio
    Prev Close:1.42
    Open:1.50
    Bid:N/A
    Ask:N/A
    1y Target Est:3.00
    Beta:1.13
    Next Earnings Date:N/A
    Day's Range:1.31 - 1.59
    52wk Range:0.47 - 2.67
    Volume:1,564,340
    Avg Vol (3m):597,136
    Market Cap:125.91M
    P/E (ttm):N/A
    EPS (ttm):-0.19
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for NVIV

    Comparison

    Symbol% ChgMkt Cap
    NVIVDown 5.21%125.91M
    ACORDown 0.02%1.65B
    ALSE 0.00%1.41M
    STEMDown 4.30%63.23M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.20
    Quarterly EPS Est (Dec-14) :-0.04
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Invivo Therapeutics Holdings Corp., a development stage biomaterials and biotechnology company, focuses on developing and commercializing technologies for the treatment of spinal cord injuries (SCI). View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback